Market Cap 358.44M
Revenue (ttm) 37.21M
Net Income (ttm) -26.39M
EPS (ttm) N/A
PE Ratio 59.82
Forward PE 169.50
Profit Margin -70.92%
Debt to Equity Ratio 0.00
Volume 300,400
Avg Vol 812,162
Day's Range N/A - N/A
Shares Out 35.31M
Stochastic %K 36%
Beta 0.41
Analysts Strong Sell
Price Target $23.33

Company Profile

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal...

Industry: Medical Devices
Sector: Healthcare
Phone: 212 489 2100
Fax: 212 489 2102
Address:
566 Queensbury Avenue, New York, United States
actuallysam
actuallysam Dec. 29 at 3:21 PM
$DCTH Growth concerns versus hopes, time will tell.
1 · Reply
brunoq14
brunoq14 Dec. 28 at 5:35 PM
$DCTH It has been a long time since the last site activation. Seasonal?
1 · Reply
merlin8121
merlin8121 Dec. 28 at 4:44 PM
$DCTH https://www.merlintrader.com/dcth-buyback-story/
0 · Reply
GioW
GioW Dec. 26 at 3:18 PM
$DCTH any predictions for Q4 results?
2 · Reply
brunoq14
brunoq14 Dec. 24 at 4:06 AM
$DCTH Strongly tempted to switch to Axsome.
1 · Reply
Miracles320
Miracles320 Dec. 19 at 11:42 AM
$DCTH can't believe i didn't sell in 2017, i was in then put the rest in at the lowest 0.0150, i didn't even know it would work out, but i just kept believing, i remember the good market maker NAMMM good guy, God Bless him, then it went up, last day it ran, i woke up to 65k in my account from 5k originally, i slept and woke up thinking it would go higher cause the pr campaign kept saying 1 dollar, i was new to the market, it was 45k still didnt sell, watched it go to pennies, could have compounded that by now into life changing money after 9 years, instead i got 230 left and thats because my only friend Kevin helped me come back twice or 3 times...now ive just been suicidal, seems so hard to make anything now a days, manipulation is insane, could have bought a nice big modern home, probably gotten married to someone...there should be a system that knows how long you've been in the market and reward you big.
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 17 at 2:40 PM
$DCTH Current Stock Price: $10.12 Contracts to trade: $10 DCTH Dec 19 2025 Call Entry: $0.48 Exit: $0.68 ROI: 42% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 15 at 6:48 PM
$DCTH Share Price: $10.01 Contract Selected: May 15, 2026 $10 Calls Buy Zone: $1.32 – $1.63 Target Zone: $2.40 – $2.93 Potential Upside: 72% ROI Time to Expiration: 150 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
OldBoy17
OldBoy17 Dec. 13 at 2:12 PM
$DCTH I am pretty sure that they would disclose on the next quarterly statement, unless the company wants to make a statement showing their strength. 2026 is the year and progress will twinkle the shorts.
0 · Reply
xcdvfxcvnbxxvsd
xcdvfxcvnbxxvsd Dec. 12 at 4:14 PM
$DCTH If Delcath would buy its own shares, when would they have to report it?
3 · Reply
Latest News on DCTH
Delcath: Temporary Headwinds Are No Cause For Concern

Nov 6, 2025, 2:15 PM EST - 7 weeks ago

Delcath: Temporary Headwinds Are No Cause For Concern


Delcath Systems, Inc. (DCTH) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 5:16 PM EST - 2 months ago

Delcath Systems, Inc. (DCTH) Q3 2025 Earnings Call Transcript


Delcath Systems to Host Third Quarter 2025 Earnings Call

Oct 21, 2025, 8:30 AM EDT - 2 months ago

Delcath Systems to Host Third Quarter 2025 Earnings Call


Delcath: Large Upside With Limited Downside Risk

Oct 20, 2025, 3:06 PM EDT - 2 months ago

Delcath: Large Upside With Limited Downside Risk


Delcath Systems, Inc. (DCTH) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 3:06 PM EDT - 5 months ago

Delcath Systems, Inc. (DCTH) Q2 2025 Earnings Call Transcript


Delcath Systems to Host Second Quarter 2025 Earnings Call

Jul 23, 2025, 4:01 PM EDT - 5 months ago

Delcath Systems to Host Second Quarter 2025 Earnings Call


Delcath Systems: Growing Fast, But Business Model Is Fragile

Jun 12, 2025, 8:36 AM EDT - 7 months ago

Delcath Systems: Growing Fast, But Business Model Is Fragile


Delcath Systems Issues Full Year 2025 Guidance

May 22, 2025, 7:00 AM EDT - 8 months ago

Delcath Systems Issues Full Year 2025 Guidance


Delcath Systems, Inc. (DCTH) Q1 2025 Earnings Call Transcript

May 8, 2025, 10:55 AM EDT - 8 months ago

Delcath Systems, Inc. (DCTH) Q1 2025 Earnings Call Transcript


Delcath Systems to Host First Quarter 2025 Earnings Call

Apr 24, 2025, 4:01 PM EDT - 8 months ago

Delcath Systems to Host First Quarter 2025 Earnings Call


Hospitals Experience FOMO In Adopting Delcath's PHP Treatment

Apr 2, 2025, 11:49 AM EDT - 9 months ago

Hospitals Experience FOMO In Adopting Delcath's PHP Treatment


Delcath Systems, Inc. (DCTH) Q4 2024 Earnings Call Transcript

Mar 6, 2025, 2:17 PM EST - 10 months ago

Delcath Systems, Inc. (DCTH) Q4 2024 Earnings Call Transcript


Biotech walks a 'tightrope' amid unclear funding, regulations

Jan 30, 2025, 7:06 PM EST - 11 months ago

Biotech walks a 'tightrope' amid unclear funding, regulations

ELVN IBB


Delcath Begins Platform Expansion With Two Phase 2 Trials

Nov 20, 2024, 7:50 AM EST - 1 year ago

Delcath Begins Platform Expansion With Two Phase 2 Trials


Delcath Systems Inc (DCTH) Q3 2024 Earnings Call Transcript

Nov 8, 2024, 12:30 PM EST - 1 year ago

Delcath Systems Inc (DCTH) Q3 2024 Earnings Call Transcript


Delcath Systems to Host Third Quarter 2024 Earnings Call

Oct 25, 2024, 8:30 AM EDT - 1 year ago

Delcath Systems to Host Third Quarter 2024 Earnings Call


actuallysam
actuallysam Dec. 29 at 3:21 PM
$DCTH Growth concerns versus hopes, time will tell.
1 · Reply
brunoq14
brunoq14 Dec. 28 at 5:35 PM
$DCTH It has been a long time since the last site activation. Seasonal?
1 · Reply
merlin8121
merlin8121 Dec. 28 at 4:44 PM
$DCTH https://www.merlintrader.com/dcth-buyback-story/
0 · Reply
GioW
GioW Dec. 26 at 3:18 PM
$DCTH any predictions for Q4 results?
2 · Reply
brunoq14
brunoq14 Dec. 24 at 4:06 AM
$DCTH Strongly tempted to switch to Axsome.
1 · Reply
Miracles320
Miracles320 Dec. 19 at 11:42 AM
$DCTH can't believe i didn't sell in 2017, i was in then put the rest in at the lowest 0.0150, i didn't even know it would work out, but i just kept believing, i remember the good market maker NAMMM good guy, God Bless him, then it went up, last day it ran, i woke up to 65k in my account from 5k originally, i slept and woke up thinking it would go higher cause the pr campaign kept saying 1 dollar, i was new to the market, it was 45k still didnt sell, watched it go to pennies, could have compounded that by now into life changing money after 9 years, instead i got 230 left and thats because my only friend Kevin helped me come back twice or 3 times...now ive just been suicidal, seems so hard to make anything now a days, manipulation is insane, could have bought a nice big modern home, probably gotten married to someone...there should be a system that knows how long you've been in the market and reward you big.
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 17 at 2:40 PM
$DCTH Current Stock Price: $10.12 Contracts to trade: $10 DCTH Dec 19 2025 Call Entry: $0.48 Exit: $0.68 ROI: 42% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 15 at 6:48 PM
$DCTH Share Price: $10.01 Contract Selected: May 15, 2026 $10 Calls Buy Zone: $1.32 – $1.63 Target Zone: $2.40 – $2.93 Potential Upside: 72% ROI Time to Expiration: 150 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
OldBoy17
OldBoy17 Dec. 13 at 2:12 PM
$DCTH I am pretty sure that they would disclose on the next quarterly statement, unless the company wants to make a statement showing their strength. 2026 is the year and progress will twinkle the shorts.
0 · Reply
xcdvfxcvnbxxvsd
xcdvfxcvnbxxvsd Dec. 12 at 4:14 PM
$DCTH If Delcath would buy its own shares, when would they have to report it?
3 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Dec. 12 at 10:23 AM
$DCTH Vivo dumped a little .. weaklings lol (got a big profit hehe)
0 · Reply
ManyThanks212
ManyThanks212 Dec. 12 at 1:12 AM
0 · Reply
Tennis_4567
Tennis_4567 Dec. 11 at 8:49 PM
$DCTH lol. A group I am in posted this idea at 2:57 PM. That is 100% the reason for this jump. Don't get all excited. more attention is nice though
6 · Reply
Scorpio808
Scorpio808 Dec. 11 at 8:14 PM
$DCTH WHOA.......What just happened?
0 · Reply
michaelsott
michaelsott Dec. 11 at 8:07 PM
$DCTH Hopefully some good news is coming. Stock should not be this low anyway!!!!
1 · Reply
alexpitti
alexpitti Dec. 11 at 8:04 PM
$DCTH what's the news boys??
2 · Reply
Sidd_F
Sidd_F Dec. 11 at 8:02 PM
$DCTH first buybacks hitting the tape?
0 · Reply
Zzzquil
Zzzquil Dec. 11 at 8:01 PM
$DCTH news? Why the spike just now
1 · Reply
brunoq14
brunoq14 Dec. 11 at 5:06 PM
$DCTH The price seems to have stabilized. Anything in the works to bring about recovery? Growth?
1 · Reply
Night_Owl_Biotech
Night_Owl_Biotech Dec. 6 at 9:04 PM
Commercial-stage oncology focused M&A has been active with 6 acquisitions YTD (still 3.5 weeks left), 4 in FY24 & 5 in FY23. They are averaging more than 1 per quarter (right side of the attachment). In May 24 MACK was technically an exit but via CVR payout so after Ono acquired DCPH in April via traditional M&A, there was a 10 month dry spell. Our investment club believes there will be an acquisition before JP Morgan, most likely SNDX by INCY. We're speculating so of course we c/b wrong. The left side of the attachment lists all available & reasonably credible candidates. $KPTI is a textbook example of why bios should exit after FDA approval. Of course KPTI may work out with 2 major reads next year (they know it works in endometrial). Because they've waited this long we believe there's no chance they sell but again o/c we c/b wrong. Same with $FENC but at least they tried Our other most likely candidates include (in order) $URGN & $ZYME $DCTH by March (3 years since the P/E financing)
1 · Reply
Playthegame06
Playthegame06 Dec. 4 at 9:45 PM
$DCTH Let me clarify…..Hepzato treatment has changed Liver Caner from a death sentence to Chronic Disease and patients are living longer. Even though I did not say it was a CURE. I said DAMN NEAR A CURE.
0 · Reply
michaelsott
michaelsott Dec. 4 at 4:26 PM
$DCTH Patience will pay off in the long run. Chopin is not even priced in yet!!!!! The shorts are starting to realize that this company is the real deal!!!! Gerard has been a straight shooter since day one and will make sure this company succeeds!
0 · Reply